• Carclo published its annual report for FY26, marking the shift from a completed turnaround to its Precision 2030 growth phase.
• Performance improved on a smaller, higher-margin base following exits from low-margin US work, with the Pennsylvania footprint streamlined into a unified operation.
• CTP saw weaker Design & Engineering activity due to long validation cycles, while Manufacturing Solutions held broadly steady as the portfolio reset bedded in.
• Speciality delivered strong growth, supported by aerospace demand and expanded precision machining capacity across the UK and France.
• The group set out targets for organic growth, returns, and lower leverage, with expansion focused on life sciences adjacencies such as drug delivery and pharma closures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carclo plc published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein.